Logo image of ANSC

AGRICULTURE & NATURAL SOLUTI (ANSC) Stock Fundamental Analysis

NASDAQ:ANSC - Nasdaq - KYG0131Y1008 - Common Stock - Currency: USD

10.871  -0.01 (-0.08%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ANSC. ANSC was compared to 0 industry peers in the Unkown industry. ANSC may be in some trouble as it scores bad on both profitability and health. ANSC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ANSC had positive earnings in the past year.
In the past year ANSC had a positive cash flow from operations.
ANSC Yearly Net Income VS EBIT VS OCF VS FCFANSC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

Industry RankSector Rank
ROA 2.23%
ROE 2.37%
ROIC N/A
ROA(3y)0.84%
ROA(5y)N/A
ROE(3y)-1.66%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANSC Yearly ROA, ROE, ROICANSC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ANSC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ANSC Yearly Profit, Operating, Gross MarginsANSC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, ANSC has about the same amount of shares outstanding.
Compared to 1 year ago, ANSC has a worse debt to assets ratio.
ANSC Yearly Shares OutstandingANSC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
ANSC Yearly Total Debt VS Total AssetsANSC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 12.03 indicates that ANSC is not in any danger for bankruptcy at the moment.
ANSC has a debt to FCF ratio of 4.42. This is a neutral value as ANSC would need 4.42 years to pay back of all of its debts.
A Debt/Equity ratio of 0.00 indicates that ANSC is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 4.42
Altman-Z 12.03
ROIC/WACCN/A
WACCN/A
ANSC Yearly LT Debt VS Equity VS FCFANSC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

ANSC has a Current Ratio of 0.02. This is a bad value and indicates that ANSC is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.02 indicates that ANSC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
ANSC Yearly Current Assets VS Current LiabilitesANSC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.14% over the past year.
EPS 1Y (TTM)38.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 60.39, ANSC can be considered very expensive at the moment.
ANSC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.03.
Industry RankSector Rank
PE 60.39
Fwd PE N/A
ANSC Price Earnings VS Forward Price EarningsANSC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 2467.14
EV/EBITDA N/A
ANSC Per share dataANSC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ANSC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGRICULTURE & NATURAL SOLUTI

NASDAQ:ANSC (8/5/2025, 8:00:01 PM)

10.871

-0.01 (-0.08%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-11 2025-08-11
Inst Owners100.75%
Inst Owner Change-0.87%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap468.76M
AnalystsN/A
Price TargetN/A
Short Float %0%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 60.39
Fwd PE N/A
P/S N/A
P/FCF 2467.14
P/OCF 2467.14
P/B 1.35
P/tB 1.35
EV/EBITDA N/A
EPS(TTM)0.18
EY1.66%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.04%
OCF(TTM)0
OCFY0.04%
SpS0
BVpS8.05
TBVpS8.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.23%
ROE 2.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)0.84%
ROA(5y)N/A
ROE(3y)-1.66%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 4.42
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 2.31%
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 12.03
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-467.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y100%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y100%
OCF growth 3YN/A
OCF growth 5YN/A